Eli Lilly Canada (LLY) Announces Health Canada has approved TALTZ for Treatment of Active Ankylosing Spondylitis

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. DFTX
8. MU
9. IBM
10. HOOD

Go back to Eli Lilly Canada (LLY) Announces Health Canada has approved TALTZ for Treatment of Active Ankylosing Spondylitis
Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1102.08 +3.51 (0.32%)
Previous Close $1098.57    52 Week High $88.16 
Open $1112.24    52 Week Low $67.88 
Day High $1119.45    P/E 255.11 
Day Low $1093.15    EPS $4.32 
Volume 3,014,837